Treatment of massive or life-threatening hemangiomas with recombinant α2a-interferon
OBJECTIVE: To assess the response of massive, life-threatening, or function-impairing hemangiomas in pediatric patients receiving daily α2a-interferon subcutaneously. METHODS: The effect of 3 or more months of subcutaneous α2a-interferon (3 mU/m2) was prospectively evaluated in 10 patients with hema...
Gespeichert in:
| Veröffentlicht in: | Otolaryngology-head and neck surgery 1997-07, Vol.117 (1), p.99-110 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | OBJECTIVE: To assess the response of massive, life-threatening, or function-impairing hemangiomas in pediatric patients receiving daily α2a-interferon subcutaneously.
METHODS: The effect of 3 or more months of subcutaneous α2a-interferon (3 mU/m2) was prospectively evaluated in 10 patients with hemangiomas necessitating medical intervention. Hemangioma characteristics and extent were initially assessed by radiographic imaging in all but one patient. α2a-interferon tolerance was monitored, and reduction in hemangioma size was recorded as marked (>50%), moderate (25% to 50%), or minimal ( |
|---|---|
| ISSN: | 0194-5998 1097-6817 |
| DOI: | 10.1016/S0194-59989770215-8 |